US and MRI of the Forefoot: Intermetatarsal Bursitis or Morton's Neuroma
NCT ID: NCT05685160
Last Updated: 2024-11-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
NA
75 participants
INTERVENTIONAL
2021-06-14
2027-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Muscle MRI in Charcot Mary Tooth Disease: a Prospective Cohort Study
NCT03550300
Musculoskeletal Non-tumoral Pathology Quantitative Perfusion
NCT02683252
Magnetic Resonance Imaging and Ultrasonography in Evaluation of Muscle Diseases
NCT05692349
Characterizing Myositis With 68Ga-FAPI PET/CT
NCT05952531
Identification of Novel Biomarkers in Early Charcot-Marie-Tooth 1A Disease
NCT07049588
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The hypothesis is, that intermetatarsal bursitis is an overlooked diagnosis in patients with metatarsalgia. As a result of sparse literature and lack of knowledge about this condition with symptoms mimicking Morton's neuroma, a part of patients diagnosed with Morton's neuroma, suffers from intermetatarsal bursitis instead.
Additionally, the investigators want to evaluate the clinical sign opening toes.
Based on clinical photos of the feet, the investigators want to document the presence of opening toes and investigate if there is a correlation with either intermetatarsal bursitis and/or Morton's neuroma.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patient group
Patients with intermetatarsal pain have ultrasound and MRI done
MRI with contrast
MRI of the forefoot with contrast (Gadovist)
Ultrasound
Ultrasound imaging of the forefoot
Control group
Healthy individuals (no forefoot pain) undergo ultrasound and MRI scan of the forefoot.
MRI with contrast
MRI of the forefoot with contrast (Gadovist)
Ultrasound
Ultrasound imaging of the forefoot
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MRI with contrast
MRI of the forefoot with contrast (Gadovist)
Ultrasound
Ultrasound imaging of the forefoot
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Pain in an intermetatarsal space (patient group)
Exclusion Criteria
* Open wounds or ongoing infection in the forefoot at the time of examination
* Persons with contraindications to participate in MRI scan
* Persons with a history of significant trauma in the forefoot, e.g. any fracture or previous surgeries in the forefoot
* Persons who have previously received treatment for Morton's neuroma in the same foot, e.g. injection (within 6 months) or operation (anytime)
* Persons with severely impaired renal function (GFR \<30 ml/min)
* Persons with a systemic inflammatory condition like rheumatoid arthritis, due to clinically silent intermetatarsal bursitis in this group (control group)
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Danish Rheumatism Association
OTHER
Hvidovre University Hospital
OTHER
Bispebjerg Hospital
OTHER
Gentofte Hospital
UNKNOWN
Rigshospitalet, Denmark
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sif Binder Larsen
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Radiology
Copenhagen, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H-20067346
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.